EV/EBITDA
-0.49
0.000.00%
Thu, 13 Mar 2025 20:05:08 GMT
Summary
- As of March 14, 2025, QLGN EV/EBITDA is -0.49, unchanged from the previous trading day.
- Over the past year, QLGN EV/EBITDA has dropped by -0.21 (-75.00%).
- QLGN EV/EBITDA is now -1125.00% below its all-time high of -0.04.
Performance
QLGN EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
QLGN EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | 0.0% | +0.7% | +1.0% |
| 1 m1 month | +7.5% | -8.0% | -11.3% |
| 3 m3 months | +15.5% | -15.3% | -20.9% |
| 6 m6 months | +32.9% | -45.1% | -62.9% |
| ytdytd | +19.7% | -19.6% | -26.3% |
| 1 y1 year | -75.0% | +9.4% | -84.5% |
| 5 y5 years | - | - | -99.9% |
QLGN EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -2.1% | -0.55 | +10.9% | |
| 3 m | 3-month | -0.48 | -2.1% | -0.65 | +24.6% |
| 6 m | 6-month | -0.48 | -2.1% | -0.90 | +45.6% |
| 1 y | 1-year | -0.20 | -145.0% | -0.90 | +45.6% |
| 3 y | 3-year | -0.04 | -1125.0% | -0.96 | +49.0% |
| 5 y | 5-year | -0.04 | -1125.0% | -6.61 | +92.6% |
| alltime | all time | -0.04 | -1125.0% | -6.61 | +92.6% |
Qualigen Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -0.49(-19.7%) |
| 2024 | -0.61(+74.3%) |
| 2023 | -0.35(+118.8%) |
| Date | Value |
|---|---|
| 2022 | -0.16(-83.7%) |
| 2021 | -0.98(-62.5%) |
| 2020 | -2.61 |
FAQ
- What is Qualigen Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Qualigen Therapeutics?
- What is QLGN EV/EBITDA year-to-date change?
- What is Qualigen Therapeutics EV/EBITDA year-on-year change?
What is Qualigen Therapeutics EV/EBITDA?
The current EV/EBITDA of QLGN is -0.49
What is the all time high EV/EBITDA for Qualigen Therapeutics?
Qualigen Therapeutics all-time high EV/EBITDA is -0.04
What is QLGN EV/EBITDA year-to-date change?
Qualigen Therapeutics EV/EBITDA has changed by +0.12 (+19.67%) since the beginning of the year
What is Qualigen Therapeutics EV/EBITDA year-on-year change?
Over the past year, QLGN EV/EBITDA has changed by -0.21 (-75.00%)